Dr. Michael Blankenship, from ima Healthcare, joins Amy & JJ to talk about a new skin cancer vaccine in trial right now. There's a new vaccine that's created a 96 percent survival rate for people with the condition. The treatment is actually a combo of a vaccine and an immunotherapy drug. About 75 percent of the patients in the trial had no recurrence of the disease. Experts say it could be one of the "single biggest developments" to fight melanoma. 

See omnystudio.com/listener for privacy information.